Daiwa Pharmaceutical Co., Ltd. [News Release]

BioBran Workshop Held in 3 Countries in Southeast Asia

Daiwa Pharmaceutical Co., Ltd., supported "Cancer Forum in Asia" in the 3 countries of Malaysia, Thailand, and Singapore. These forums were held by local distributors. Dr. M. Ghoneum (professor at UCLA/Drew Medical School), who is a world authority of immunology and a member of the development team for BioBran, attended these forums. His lecture and the subsequent questions and answers were successfully done in each place.
The forum in Malaysia on July 27 (Tue) had the theme "New Approach to Cancer Treatment: NK Cell and Apoptosis Activation effects of BioBran." About 80 physicians and health professionals attended the meeting. The lecture, including up-to-date cases by Dr. Ghoneum, was well received. The subsequent questions and answers took more than 1 hour, well over the planned time.
A seminar for doctors and researchers was given in Bangkok, Thailand, on July 29 (Wed) (jointly hosted by an organization affiliated with Thailand's government, the National Innovation Agency), and about 100 people attended this seminar and were interested in Dr. Ghoneum's lecture. Then, a seminar for general attendees was also held in Thailand, and over 80 people joined and listened to lectures and questions and answers.
A similar seminar was given in Singapore on July 31 (Sat). Over 80 attendees, consisting mainly of doctors, listened to Dr. Ghoneum's lecture, the presentation of cooperative study results by Dr. Ghoneum and 3 researchers, and the panel discussion.
A press conference with representatives of the principal newspapers and business publications was also held in each of the 3 countries. Dr. Ghoneum attended the press conferences in Malaysia and Singapore and gave a lecture, followed by high-level questions and answers. This showed the media's deep interest in BioBran.
Daiwa Pharmaceutical intends to hold this type of workshop regularly in more countries in the future.

・